6-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of March 18, 2020

Commission File Number: 001-39152

FSD PHARMA INC.
(Translation of registrant's name into English)

520 William Street
Cobourg, Ontario
K9A 3A5
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [  ]      Form 40-F [ X ]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):             

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):             

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	FSD Pharma Inc.
	(Registrant)
Date: March 18, 2020	By: /s/ Raza Bokhari
	Name: Raza Bokhari
	Title: Executive Co-Chairman and Chief Executive Officer

EXHIBIT INDEX

Exhibit Number	Description
99.1	Amended and Restated License Agreement

EX-99.1

- 12 ·-

- 13 -

IN WITNESS WHEREOF, the parties have executed this Agreement affective as of the Effective Date.

EPITECH GROUP SPA
By:	Signed by "Raffaella della Valle"
	Name: Raffaella della Valle Title: CEO
FSD PHARMA INC
By:	Signed by "Raza Bokhari"
	Name: Raza Bokhari; MD Title: Chairman & CEO

<competitively sensitive pricing terms redacted>